LAUSR

20 Elshershari H, Cao QL, Hijazi ZM. Transcatheter device closure of atrial septal defects in patients older than 60 years of age: immediate and followup results. J Invasive Cardiol 2008;20:173–6. 21 Chiu SN, Wu MH, Tsai CT, et al. Atrial flutter/fibrillation in patients receiving transcatheter closure of atrial septal defect. J Formos Med Assoc 2017;116:522–8. 22 Woo SB, Jang SI, Kim SH, et al. Transcatheter closure of secundum atrial septal defect in patients over 60 years old. Korean Circ J 2013;43:110. 23 Wi J, Choi JY, Shim JM, et al. Fate of preoperative atrial fibrillation after correction of atrial septal defect. Circ J 2013;77:109–15. 24 AlHindi A, Cao QL, Hijazi ZM. Transcatheter closure of secundum atrial septal defect in the elderly. J Invasive Cardiol 2009;21:47–51. 25 Meyer MR, Kurz DJ, Bernheim AM, et al. Efficacy and safety of transcatheter closure in adults with large or small atrial septal defects. Springerplus 2016;5:1–8. 26 Kokocińska E, Maicka A, Kolińska J, et al. Transcatheter implantation of atrial septal occluders in adult patients – evaluation of longterm outcome. Pwki 2011;2:116–21. 27 Humenberger M, Rosenhek R, Gabriel H, et al. Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J 2011;32:553–60. 28 Giardini A, Donti A, Sciarra F, et al. Longterm incidence of atrial fibrillation and flutter after transcatheter atrial septal defect closure in adults. Int J Cardiol 2009;134:47–51. 29 Duong P, Ferguson LP, Lord S, et al. Atrial arrhythmia after transcatheter closure of secundum atrial septal defects in patients ≥40 years of age. EP Europace 2017;19:1322–6. 30 Schneeberger Y, Schaefer A, Conradi L, et al. Minimally invasive endoscopic surgery versus catheterbased device occlusion for atrial septal defects in adults: Reconsideration of the standard of care. Interact Cardiovasc Thorac Surg 2017;24:603–8. 31 Rosas M, Zabal C, GarciaMontes J, et al. Transcatheter versus surgical closure of secundum atrial septal defect in adults: impact of age at intervention. A concurrent matched comparative study. Congenit Heart Dis 2007;2:148–55. 32 Majunke N, Bialkowski J, Wilson N, et al. Closure of atrial septal defect with the Amplatzer septal occluder in adults. Am J Cardiol 2009;103:550–4. 33 Knepp MD, Rocchini AP, Lloyd TR, et al. Long-term follow up of secundum atrial septal defect closure with the amplatzer septal occluder. Congenit Heart Dis 2010;5:32–7. 34 de Hemptinne Q, Horlick EM, Osten MD, et al. Initial clinical experience with the GORE CARDIOFORM ASD occluder for transcatheter atrial septal defect closure. Catheter Cardiovasc Interv 2017;90:495–503. 35 Boudiche S, Chatti S, Amroussia R, et al. Atrial septal defect closure in adults: a tenyear experience. Tunis Med 2019;97:1362–9. 36 Snijder RJR, Renes LE, Bosshardt D, et al. Percutaneous atrial septal defect closure using the occlutech figulla device in adults: more than 800 patientyears of followup. J Interv Cardiol 2020;2020:1–5. 37 Ortega MC, Ramos DBB, Novoa JCR, et al. Impact of transcatheter device closure of atrial septal defect on atrial arrhythmias propensity in young adults. Pediatr Cardiol 2020;41:54–61. 38 Kamioka M, Yoshihisa A, Hijioka N, et al. The efficacy of combination of transcatheter atrial septal defects closure and radiofrequency catheter ablation for the prevention of atrial fibrillation recurrence through biatrial reverse remodeling. J Interv Card Electrophysiol 2020;59:365–72. 39 Kadirogullari E, Onan B, Timur B, et al. Transcatheter closure vs totally endoscopic robotic surgery for atrial septal defect closure: a singlecenter experience. J Card Surg 2020;35:764–71. 40 Fujii Y, Akagi T, Nakagawa K, et al. Clinical impact of transcatheter atrial septal defect closure on new onset atrial fibrillation in adult patients: comparison with surgical closure. J Cardiol 2020;76:94–9. 41 Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg 1999;68:75–8. 42 Mojadidi MK, Mahmoud AN, Mahtta D, et al. Incidence and causes of 30day readmissions after surgical versus percutaneous secundum atrial septal defect closure: a United States nationwide analysis. Structural Heart 2019;3:113–20. 43 Williams BA, Chamberlain AM, Blankenship JC, et al. Trends in atrial fibrillation incidence rates within an integrated health care delivery system, 2006 to 2018. JAMA Netw Open 2020;3:e2014874. 44 Abrahamyan L, Dharma C, Alnasser S, et al. Longterm outcomes after atrial septal defect transcatheter closure by age and against population controls. JACC Cardiovasc Interv 2021;14:566–75. 45 Konstantinides S, Geibel A, Olschewski M, et al. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med 1995;333:469–73. 46 Shah D, Azhar M, Oakley CM, et al. Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J 1994;71:224–8. 47 Nyboe C, Olsen MS, NielsenKudsk JE, et al. Atrial fibrillation and stroke in adult patients with atrial septal defect and the longterm effect of closure. Heart 2015;101:706–11.